Holen Sie sich die Stockscreener-App
254.95
3.18%
7.86
Handel nachbörslich:
254.95
Schlusskurs vom Vortag:
$247.09
Offen:
$251.04
24-Stunden-Volumen:
240.46K
Relative Volume:
0.83
Marktkapitalisierung:
$7.45B
Einnahmen:
$389.13M
Nettoeinkommen (Verlust:
$204.83M
KGV:
37.25
EPS:
6.8443
Netto-Cashflow:
$188.91M
1W Leistung:
+1.64%
1M Leistung:
-6.44%
6M Leistung:
+58.21%
1J Leistung:
+32.58%
1-Tages-Spanne:
$250.91
$257.65
1-Wochen-Bereich:
$243.18
$263.75
52-Wochen-Spanne:
$122.80
$298.30
Krystal Biotech Inc Stock (KRYS) Company Profile
Firmenname
Krystal Biotech Inc
Sektor
Branche
Telefon
(412) 586-5830
Adresse
2100 WHARTON STREET, PITTSBURGH, PA
Compare KRYS vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
254.95 | 7.22B | 389.13M | 204.83M | 188.91M | 6.8443 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-03-05 | Eingeleitet | Jefferies | Buy |
| 2024-08-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-11-20 | Eingeleitet | Goldman | Buy |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-12 | Eingeleitet | Citigroup | Buy |
| 2023-09-07 | Eingeleitet | Berenberg | Buy |
| 2023-04-18 | Eingeleitet | Stifel | Buy |
| 2023-02-28 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-25 | Herabstufung | Goldman | Buy → Neutral |
| 2022-01-18 | Eingeleitet | BofA Securities | Buy |
| 2021-07-20 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-18 | Eingeleitet | B. Riley FBR | Buy |
| 2020-06-04 | Eingeleitet | Evercore ISI | Outperform |
| 2019-09-24 | Eingeleitet | Goldman | Neutral |
| 2019-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-24 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-06-24 | Bestätigt | H.C. Wainwright | Buy |
| 2019-05-30 | Eingeleitet | Guggenheim | Buy |
| 2018-09-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Krystal Biotech Inc Aktie (KRYS) Neueste Nachrichten
Fed Watch: Is Krystal Biotech Inc impacted by rising rates2026 EndofMonth & Verified Swing Trading Watchlist - baoquankhu1.vn
BofA Securities Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $325 - Moomoo
Published on: 2026-03-23 18:50:19 - baoquankhu1.vn
Why is Krystal Biotech (KRYS) down 11.5% since last earnings report? - MSN
Krystal Biotech slips more than 2% even after Q4 earnings and revenue top estimates - MSN
KRYS SEC FilingsKrystal Biotech 10-K, 10-Q, 8-K Forms - Stock Titan
OCGN Gene Therapy Pipeline: 2026-2027 Catalysts To Watch - The Globe and Mail
Krystal Biotech Experiences Revision in Its Stock Evaluation Amid Strong Financial Performance - Markets Mojo
(KRYS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
A Look At Krystal Biotech (KRYS) Valuation After Updated Vyjuvek Label And Pipeline Momentum - simplywall.st
Why has Krystal Biotech (KRYS) dropped 11.5% following its most recent earnings announcement? - Bitget
Why Is Krystal Biotech (KRYS) Down 11.5% Since Last Earnings Report? - Yahoo Finance
Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025 - AOL.com
Quarterly Trades: Is Krystal Biotech Inc impacted by rising ratesMarket Risk Report & Daily Growth Stock Investment Tips - baoquankhu1.vn
Vyjuvek Label Update And KB803 Progress Reshape Krystal Biotech Story - simplywall.st
Is It Too Late To Consider Krystal Biotech (KRYS) After Strong Multi‑Year Share Gains? - Yahoo Finance
Guidance Update: Can Krystal Biotech Inc weather a recession2026 Summary & Expert-Curated Trade Recommendations - baoquankhu1.vn
Updated YJUVEK Label and KB803 Progress Could Be A Game Changer For Krystal Biotech (KRYS) - Yahoo Finance
Whale Trades: Can Krystal Biotech Inc weather a recessionWeekly Stock Recap & Verified Chart Pattern Signals - baoquankhu1.vn
What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment - The Motley Fool
Decheng Capital LLC Sells 33,700 Shares of Krystal Biotech, Inc. $KRYS - MarketBeat
Braidwell LP Cuts Holdings in Krystal Biotech, Inc. $KRYS - MarketBeat
Avoro Capital Advisors LLC Purchases 117,777 Shares of Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech Stock Surges on Q4 Beat, But Valuation Questions Linger After CEO Share Sale - AD HOC NEWS
Assessing Krystal Biotech (KRYS) Valuation After Q4 2025 Beat And CEO Stock Sale - simplywall.st
First Trust Advisors LP Has $43.85 Million Stake in Krystal Biotech, Inc. $KRYS - MarketBeat
Capital World Investors Cuts Position in Krystal Biotech, Inc. $KRYS - MarketBeat
8,212 Shares in Krystal Biotech, Inc. $KRYS Bought by WINTON GROUP Ltd - MarketBeat
The Bull Case For Krystal Biotech (KRYS) Could Change Following Q4 Beat And CEO Stock Sales - Sahm
Krystal Biotech Insider Sold Shares Worth $6,580,270, According to a Recent SEC Filing - marketscreener.com
(KRYS) Risk Channels and Responsive Allocation - Stock Traders Daily
Krystal Biotech, Inc. $KRYS Position Trimmed by GW&K Investment Management LLC - MarketBeat
Krishnan Krish S, president of Krystal Biotech, sells $6.58 million in KRYS stock - Investing.com
Krystal Biotech (NASDAQ:KRYS) Insider Sells $6,580,250.00 in Stock - MarketBeat
Krystal Biotech director Krishnan sells $6.58 million in shares By Investing.com - Investing.com Nigeria
Krystal Biotech director Krishnan sells $6.58 million in shares - Investing.com
Krystal Biotech (KRYS) R&D president sells 25,000 shares under 10b5-1 plan - Stock Titan
[Form 4] Krystal Biotech, Inc. Insider Trading Activity - Stock Titan
KRYS Earnings History & Surprises | EPS & Revenue Results | KRYSTAL BIOTECH INC (NASDAQ:KRYS) - ChartMill
[144] Krystal Biotech, Inc. SEC Filing - Stock Titan
Segall Bryant & Hamill LLC Lowers Stock Position in Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech at TD Cowen Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Kathryn Romano Sells 750 Shares of Krystal Biotech (NASDAQ:KRYS) Stock - MarketBeat
Daniel Janney Sells 11,803 Shares of Krystal Biotech (NASDAQ:KRYS) Stock - MarketBeat
Daniel Janney sells Krystal Biotech (KRYS) shares worth $3.25 million By Investing.com - Investing.com Canada
Daniel Janney sells Krystal Biotech (KRYS) shares worth $3.25 million - Investing.com
Krystal Biotech (KRYS) CAO sells shares and receives fresh stock awards - Stock Titan
Krystal Biotech (KRYS) R&D chief logs new awards, PSU vesting and tax trades - Stock Titan
Krystal Biotech (NASDAQ: KRYS) CEO reports new equity awards and tax share surrenders - Stock Titan
Alta Bioequities linked to Krystal Biotech (KRYS) director sells 11,803 shares - Stock Titan
Krystal Biotech, Inc. $KRYS Position Increased by William Blair Investment Management LLC - MarketBeat
Finanzdaten der Krystal Biotech Inc-Aktie (KRYS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):